Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1994 Jun;112(2):505–514. doi: 10.1111/j.1476-5381.1994.tb13102.x

Binding and functional properties of hexocyclium and sila-hexocyclium derivatives to muscarinic receptor subtypes.

M Waelbroeck 1, J Camus 1, M Tastenoy 1, R Feifel 1, E Mutschler 1, R Tacke 1, C Strohmann 1, K Rafeiner 1, J F Rodrigues de Miranda 1, G Lambrecht 1
PMCID: PMC1910350  PMID: 8075869

Abstract

1. We have compared the binding properties of several hexocyclium and sila-hexocyclium derivatives to muscarinic M1 receptors (in rat brain, human neuroblastoma (NB-OK 1) cells and calf superior cervical ganglia), rat heart M2 receptors, rat pancreas M3 receptors and M4 receptors in rat striatum, with their functional antimuscarinic properties in rabbit vas deferens (M1/M4-like), guinea-pig atria (M2), and guinea-pig ileum (M3) muscarinic receptors. 2. Sila-substitution (C/Si exchange) of hexocyclium (-->sila-hexocyclium) and demethyl-hexocyclium (-->demethyl-sila-hexocyclium) did not significantly affect their affinities for muscarinic receptors. By contrast, sila-substitution of o-methoxy-hexocyclium increased its affinity 2 to 3 fold for all the muscarinic receptor subtypes studied. 3. The p-fluoro- and p-chloro-derivatives of sila-hexocyclium had lower affinities than the parent compound at the four receptor subtypes, in binding and pharmacological studies. 4. In binding studies, o-methoxy-sila-hexocyclium (M1 = M4 > or = M3 > or = M2) had a much lower affinity than sila-hexocyclium for the four receptor subtypes, and discriminated the receptor subtypes more poorly than sila-hexocyclium (M1 = M3 > M4 > M2). This is in marked contrast with the very clear selectivity of o-methoxy-sila-hexocyclium for the prejunctional M1/M4-like heteroreceptors in rabbit vas deferens. 5. The tertiary amines demethyl-hexocyclium, demethyl-sila-hexocyclium and demethyl-o-methoxy-sila-hexocyclium had 10 to 30 fold lower affinities than the corresponding quaternary ammonium derivatives.

Full text

PDF
505

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barlow R. B., Chan M. The effects of pH on the affinity of pirenzepine for muscarinic receptors in the guinea-pig ileum and rat fundus strip. Br J Pharmacol. 1982 Nov;77(3):559–563. doi: 10.1111/j.1476-5381.1982.tb09331.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barlow R. B., Weston-Smith P. The relative potencies of some agonists at M2 muscarinic receptors in guinea-pig ileum, atria and bronchi. Br J Pharmacol. 1985 Jun;85(2):437–440. doi: 10.1111/j.1476-5381.1985.tb08879.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Boddeke H. W. Different effects of muscarinic agonists in rat superior cervical ganglion and hippocampal slices. Eur J Pharmacol. 1991 Aug 29;201(2-3):191–197. doi: 10.1016/0014-2999(91)90344-p. [DOI] [PubMed] [Google Scholar]
  5. Buckley N. J., Bonner T. I., Buckley C. M., Brann M. R. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol Pharmacol. 1989 Apr;35(4):469–476. [PubMed] [Google Scholar]
  6. Caulfield M. P. Muscarinic receptors--characterization, coupling and function. Pharmacol Ther. 1993 Jun;58(3):319–379. doi: 10.1016/0163-7258(93)90027-b. [DOI] [PubMed] [Google Scholar]
  7. Cheng Y., Prusoff W. H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973 Dec 1;22(23):3099–3108. doi: 10.1016/0006-2952(73)90196-2. [DOI] [PubMed] [Google Scholar]
  8. Choo L. K., Mitchelson F. Selective inhibition of responses to carbachol and McN-A-343 in the rabbit vas deferens. Clin Exp Pharmacol Physiol. 1990 Sep;17(9):601–611. doi: 10.1111/j.1440-1681.1990.tb01361.x. [DOI] [PubMed] [Google Scholar]
  9. Doods H. N., Willim K. D., Boddeke H. W., Entzeroth M. Characterization of muscarinic receptors in guinea-pig uterus. Eur J Pharmacol. 1993 Dec 7;250(2):223–230. doi: 10.1016/0014-2999(93)90385-u. [DOI] [PubMed] [Google Scholar]
  10. Dörje F., Friebe T., Tacke R., Mutschler E., Lambrecht G. Novel pharmacological profile of muscarinic receptors mediating contraction of the guinea-pig uterus. Naunyn Schmiedebergs Arch Pharmacol. 1990 Sep;342(3):284–289. doi: 10.1007/BF00169439. [DOI] [PubMed] [Google Scholar]
  11. Dörje F., Wess J., Lambrecht G., Tacke R., Mutschler E., Brann M. R. Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J Pharmacol Exp Ther. 1991 Feb;256(2):727–733. [PubMed] [Google Scholar]
  12. Ellis J. Method for comparing selectivities of unlabeled subpopulation-selective ligands: application to muscarinic receptors. J Recept Res. 1988;8(6):885–900. doi: 10.3109/10799898809049032. [DOI] [PubMed] [Google Scholar]
  13. Eltz M., Gmelin G., Wess J., Strohmann C., Tacke R., Mutschler E., Lambrecht G. Presynaptic muscarinic receptors mediating inhibition of neurogenic contractions in rabbit vas deferens are of the ganglionic M1-type. Eur J Pharmacol. 1988 Dec 13;158(3):233–242. doi: 10.1016/0014-2999(88)90072-6. [DOI] [PubMed] [Google Scholar]
  14. Eltze M. Muscarinic M1- and M2-receptors mediating opposite effects on neuromuscular transmission in rabbit vas deferens. Eur J Pharmacol. 1988 Jul 7;151(2):205–221. doi: 10.1016/0014-2999(88)90801-1. [DOI] [PubMed] [Google Scholar]
  15. Eltze M., Ullrich B., Mutschler E., Moser U., Bungardt E., Friebe T., Gubitz C., Tacke R., Lambrecht G. Characterization of muscarinic receptors mediating vasodilation in rat perfused kidney. Eur J Pharmacol. 1993 Jul 20;238(2-3):343–355. doi: 10.1016/0014-2999(93)90866-g. [DOI] [PubMed] [Google Scholar]
  16. Feifel R., Rodrigues de Miranda J. F., Strohmann C., Tacke R., Aasen A. J., Mutschler E., Lambrecht G. Selective labelling of muscarinic M1 receptors in calf superior cervical ganglia by [3H](+/-)-telenzepine. Eur J Pharmacol. 1991 Mar 19;195(1):115–123. doi: 10.1016/0014-2999(91)90388-7. [DOI] [PubMed] [Google Scholar]
  17. Grimm U., Fuder H., Moser U., Bümert H. G., Mutschler E., Lambrecht G. Characterization of the prejunctional muscarinic receptors mediating inhibition of evoked release of endogenous noradrenaline in rabbit isolated vas deferens. Naunyn Schmiedebergs Arch Pharmacol. 1994 Jan;349(1):1–10. doi: 10.1007/BF00178199. [DOI] [PubMed] [Google Scholar]
  18. Hammer R., Berrie C. P., Birdsall N. J., Burgen A. S., Hulme E. C. Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature. 1980 Jan 3;283(5742):90–92. doi: 10.1038/283090a0. [DOI] [PubMed] [Google Scholar]
  19. Hulme E. C., Birdsall N. J., Buckley N. J. Muscarinic receptor subtypes. Annu Rev Pharmacol Toxicol. 1990;30:633–673. doi: 10.1146/annurev.pa.30.040190.003221. [DOI] [PubMed] [Google Scholar]
  20. Kopp R., Lambrecht G., Mutschler E., Moser U., Tacke R., Pfeiffer A. Human HT-29 colon carcinoma cells contain muscarinic M3 receptors coupled to phosphoinositide metabolism. Eur J Pharmacol. 1989 Oct 17;172(4-5):397–405. doi: 10.1016/0922-4106(89)90021-7. [DOI] [PubMed] [Google Scholar]
  21. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  22. Lambrecht G., Feifel R., Wagner-Röder M., Strohmann C., Zilch H., Tacke R., Waelbroeck M., Christophe J., Boddeke H., Mutschler E. Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes. Eur J Pharmacol. 1989 Sep 1;168(1):71–80. doi: 10.1016/0014-2999(89)90634-1. [DOI] [PubMed] [Google Scholar]
  23. Lambrecht G., Gmelin G., Rafeiner K., Strohmann C., Tacke R., Mutschler E. o-Methoxy-sila-hexocyclium: a new quaternary M1-selective muscarinic antagonist. Eur J Pharmacol. 1988 Jun 22;151(1):155–156. doi: 10.1016/0014-2999(88)90708-x. [DOI] [PubMed] [Google Scholar]
  24. Lambrecht G., Moser U., Grimm U., Pfaff O., Hermanni U., Hildebrandt C., Waelbroeck M., Christophe J., Mutschler E. New functionally selective muscarinic agonists. Life Sci. 1993;52(5-6):481–488. doi: 10.1016/0024-3205(93)90305-m. [DOI] [PubMed] [Google Scholar]
  25. Lazareno S., Birdsall N. J. Pharmacological characterization of acetylcholine-stimulated [35S]-GTP gamma S binding mediated by human muscarinic m1-m4 receptors: antagonist studies. Br J Pharmacol. 1993 Aug;109(4):1120–1127. doi: 10.1111/j.1476-5381.1993.tb13738.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lazareno S., Buckley N. J., Roberts F. F. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells. Mol Pharmacol. 1990 Dec;38(6):805–815. [PubMed] [Google Scholar]
  27. Micheletti R., Giudici L., Turconi M., Donetti A. 4-DAMP analogues reveal heterogeneity of M1 muscarinic receptors. Br J Pharmacol. 1990 Jul;100(3):395–397. doi: 10.1111/j.1476-5381.1990.tb15816.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Micheletti R., Schiavone A., Cereda E., Donetti A. Hexocyclium derivatives with a high selectivity for smooth muscle muscarinic receptors. Br J Pharmacol. 1990 May;100(1):150–152. doi: 10.1111/j.1476-5381.1990.tb12067.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Mutschler E., Hultzsch K. Uber Struktur-Wirkungs-Beziehungen von ungesättigten Estern des Arecaidins und Dihydroarecaidins. Arzneimittelforschung. 1973 May;23(5):732–737. [PubMed] [Google Scholar]
  30. Nelson W. L., Freeman D. S., Vincenzi F. F. Stereochemical analogs of a muscarinic, ganglionic stimulant. 2. Cis and trans olefinic, epoxide, and cyclopropane analogs related to 4-[N-(3-chlorophenyl)carbamoyloxy]-2-butynyltrimethylammonium chloride (McN-A-343). J Med Chem. 1976 Jan;19(1):153–158. doi: 10.1021/jm00223a026. [DOI] [PubMed] [Google Scholar]
  31. PATON W. D., RANG H. P. THE UPTAKE OF ATROPINE AND RELATED DRUGS BY INTESTINAL SMOOTH MUSCLE OF THE GUINEA-PIG IN RELATION TO ACETYLCHOLINE RECEPTORS. Proc R Soc Lond B Biol Sci. 1965 Aug 24;163:1–44. doi: 10.1098/rspb.1965.0058. [DOI] [PubMed] [Google Scholar]
  32. Paton W. D., Zar M. A. The origin of acetylcholine released from guinea-pig intestine and longitudinal muscle strips. J Physiol. 1968 Jan;194(1):13–33. doi: 10.1113/jphysiol.1968.sp008392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Pfeiffer A., Hanack C., Kopp R., Tacke R., Moser U., Mutschler E., Lambrecht G., Herawi M. Human gastric mucosa expresses glandular M3 subtype of muscarinic receptors. Dig Dis Sci. 1990 Dec;35(12):1468–1472. doi: 10.1007/BF01540563. [DOI] [PubMed] [Google Scholar]
  34. Pfeiffer A., Rochlitz H., Noelke B., Tacke R., Moser U., Mutschler E., Lambrecht G. Muscarinic receptors mediating acid secretion in isolated rat gastric parietal cells are of M3 type. Gastroenterology. 1990 Jan;98(1):218–222. doi: 10.1016/0016-5085(90)91314-v. [DOI] [PubMed] [Google Scholar]
  35. Polidori C., Massi M., Lambrecht G., Mutschler E., Tacke R., Melchiorre C. Selective antagonists provide evidence that M1 muscarinic receptors may mediate carbachol-induced drinking in the rat. Eur J Pharmacol. 1990 Apr 10;179(1-2):159–165. doi: 10.1016/0014-2999(90)90413-z. [DOI] [PubMed] [Google Scholar]
  36. Tacke R., Zilch H. Sila-substitution--a useful strategy for drug design? Endeavour. 1986;10(4):191–197. doi: 10.1016/0160-9327(86)90093-1. [DOI] [PubMed] [Google Scholar]
  37. Tallarida R. J., Cowan A., Adler M. W. pA2 and receptor differentiation: a statistical analysis of competitive antagonism. Life Sci. 1979 Aug 20;25(8):637–654. doi: 10.1016/0024-3205(79)90505-8. [DOI] [PubMed] [Google Scholar]
  38. VAN ROSSUM J. M. Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn Ther. 1963;143:299–330. [PubMed] [Google Scholar]
  39. Waelbroeck M., Camus J., Tastenoy M., Christophe J. 80% of muscarinic receptors expressed by the NB-OK 1 human neuroblastoma cell line show high affinity for pirenzepine and are comparable to rat hippocampus M1 receptors. FEBS Lett. 1988 Jan 4;226(2):287–290. doi: 10.1016/0014-5793(88)81441-8. [DOI] [PubMed] [Google Scholar]
  40. Waelbroeck M., Camus J., Winand J., Christophe J. Different antagonist binding properties of rat pancreatic and cardiac muscarinic receptors. Life Sci. 1987 Nov 9;41(19):2235–2240. doi: 10.1016/0024-3205(87)90521-2. [DOI] [PubMed] [Google Scholar]
  41. Waelbroeck M., Gillard M., Robberecht P., Christophe J. Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type. Mol Pharmacol. 1987 Jul;32(1):91–99. [PubMed] [Google Scholar]
  42. Waelbroeck M., Tastenoy M., Camus J., Christophe J. Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain. Mol Pharmacol. 1990 Aug;38(2):267–273. [PubMed] [Google Scholar]
  43. Waelbroeck M., Tastenoy M., Camus J., Christophe J., Strohmann C., Linoh H., Zilch H., Tacke R., Mutschler E., Lambrecht G. Binding and functional properties of antimuscarinics of the hexocyclium/sila-hexocyclium and hexahydro-diphenidol/hexahydro-sila-diphenidol type to muscarinic receptor subtypes. Br J Pharmacol. 1989 Sep;98(1):197–205. doi: 10.1111/j.1476-5381.1989.tb16882.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES